By down-regulating the NFκB activity, TQ treatment also down-regulates the expression of Bcl-2, Bcl-Xl and XIAP leading to mitochondrial-induced apoptosis via activation and cleavage of caspases in ABC cells. The gene discussed is BCL2; the disease is aneurysmal bone cyst.